LAT1-overexpressing models exhibit enhanced boron uptake, greater BNCT efficacy, and favorable tumor-to-background ratios using LAT1-specific PET tracers such as [18F]-FBPA and [18F]-FBY (15–18). Here, SLC7A5 is linked to neoplasm.